Akero Therapeutics Inc buy UBS Group AG
Start price
12.10.23
/
50%
€14.00
Target price
12.10.24
€37.01
Performance (%)
92.86%
End price
13.10.24
€27.00
Summary
This prediction ended on 13.10.24 with a price of €27.00. The BUY prediction by UBS_Group_AG for Akero Therapeutics Inc saw massive gains of 92.86%. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Akero Therapeutics Inc | - | - | - |
| iShares Core DAX® | -6.016% | -4.595% | 1.274% |
| iShares Nasdaq 100 | 0.511% | 0.164% | 14.573% |
| iShares Nikkei 225® | -7.156% | -2.215% | 28.107% |
| iShares S&P 500 | -0.257% | -0.841% | 10.196% |
Comments by UBS_Group_AG for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target lowered by analysts at UBS Group AG from $83.00 to $39.00. They now have a "buy" rating on the stock.
Ratings data for AKRO provided by MarketBeat
In the thread Trading Akero Therapeutics Inc
Die von UBS_Group_AG gewählte maximale Laufzeit wurde überschritten
Stopped prediction by UBS_Group_AG for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€52.08
31.01.25
31.01.25
€105.08
31.01.26
31.01.26
-9.81%
01.02.26
01.02.26
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€26.60
05.03.24
05.03.24
€38.62
05.03.25
05.03.25
54.62%
06.03.25
06.03.25
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€46.20
28.08.23
28.08.23
€76.75
28.08.24
28.08.24
-48.68%
29.08.24
29.08.24